KDM4C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.114240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.744800E-01
Normal-vs-Stage2
1.399830E-01
Normal-vs-Stage3
2.599600E-01
Normal-vs-Stage4
5.683200E-01
Stage1-vs-Stage2
9.228400E-01
Stage1-vs-Stage3
2.918100E-02
Stage1-vs-Stage4
2.716600E-01
Stage2-vs-Stage3
4.68389999996877E-06
Stage2-vs-Stage4
4.582400E-01
Stage3-vs-Stage4
4.124200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.349840E-01
Normal-vs-AfricanAmerican
4.077000E-01
Normal-vs-Asian
3.616800E-01
Caucasian-vs-AfricanAmerican
7.546400E-01
Caucasian-vs-Asian
3.892200E-01
AfricanAmerican-vs-Asian
6.773600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.400200E-01
Normal-vs-Female
4.045200E-01
Male-vs-Female
1.794750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.573400E-01
Normal-vs-Age(41-60Yrs)
4.714400E-01
Normal-vs-Age(61-80Yrs)
1.857790E-01
Normal-vs-Age(81-100Yrs)
3.406400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.621800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.659800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.325200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.083400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.634300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.008580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.064600E-01
Normal-vs-Daily Drinker
3.708600E-01
Normal-vs-Weekly Drinker
1.709430E-01
Normal-vs-Occasional Drinker
4.362600E-01
Normal-vs-Social Drinker
4.557000E-01
Non Drinker-vs-Daily Drinker
6.499000E-01
Non Drinker-vs-Weekly Drinker
8.110200E-01
Non Drinker-vs-Occasional Drinker
7.268000E-01
Non Drinker-vs-Social Drinker
6.346800E-01
Daily Drinker-vs-Weekly Drinker
5.479600E-01
Daily Drinker-vs-Occasional Drinker
4.090000E-01
Daily Drinker-vs-Social Drinker
3.690400E-01
Weekly Drinker-vs-Occasional Drinker
9.653800E-01
Weekly Drinker-vs-Social Drinker
8.634400E-01
Occasional Drinker-vs-Social Drinker
8.584600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.027640E-01
Normal-vs-Grade 2
2.156500E-02
Normal-vs-Grade 3
2.278400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.384000E-01
Grade 1-vs-Grade 3
3.650400E-01
Grade 1-vs-Grade 4
1.027640E-01
Grade 2-vs-Grade 3
3.620400E-01
Grade 2-vs-Grade 4
2.156500E-02
Grade 3-vs-Grade 4
2.278400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.416000E-01
Normal-vs-NonDiabetic
3.976000E-01
Diabetic-vs-NonDiabetic
3.184200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.586200E-01
Normal-vs-NoPancreatitis
1.176770E-01
Pancreatitis-vs-NoPancreatitis
5.268800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.096000E-01
Normal-vs-N1
4.171000E-01
N0-vs-N1
2.795600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.278400E-01
Normal-vs-TP53-NonMutant
5.458200E-01
TP53-Mutant-vs-TP53-NonMutant
6.603200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
